Consort Medical's competitors

Consort Medical's competitors include BioScrip, Cytokinetics, Horizon Pharma and Valeant Pharmaceuticals International
Add company...
Consort Medical
Consort Medical is a healthcare company focused on medical device technologies for drug delivery.
BioScrip
We are a national post-acute solutions provider with over 30 years of experience.
Cytokinetics
We are focused on discovering and developing muscle activators as drug candidates for debilitating diseases.
Horizon Pharma
Horizon Pharma plc (NASDAQ:HZNP) is a biopharmaceutical company with corporate and EU headquarters in Dublin, Ireland and U.S. headquarters in Lake Forest, IL
Valeant Pharmaceuticals International
Valeant Pharmaceuticals International is a multinational specialty pharmaceutical and medical device company.
Founding Date
Founding Date
N/A
Founding Date
N/A
Founding Date
1997
Founding Date
2008
Founding Date
1960
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Hemel Hempstead, GB HQ
Monheim Am Rhein, DE
Zwickau, DE
Pianezza, IT
Nelson, GB
Wolverton, GB
Cambridge, GB
see more
Locations
Denver, US HQ
Eden Prairie, US
Elmsford, US
Locations
South San Francisco, US HQ
Locations
Ballsbridge, IE HQ
Mannheim, DE
Reinach, CH
Chicago, US
Lake Forest, US
Roswell, US
Locations
Aliso Viejo, US HQ
Employees
Employees
2,0986% increase
Employees
2,039
Employees
127
Employees
9359% decrease
Employees
21,500
Valuation ($)
Valuation ($)
721 m
Valuation ($)
321.2 m
Valuation ($)
476.9 m
Valuation ($)
2.7 b
Valuation ($)
7.8 b
Facebook likes
Facebook likes
N/A
Facebook likes
745
Facebook likes
N/A
Facebook likes
N/A
Facebook likes
551
Twitter followers
Twitter followers
134
Twitter followers
291
Twitter followers
680
Twitter followers
2 k
Twitter followers
585

Financial

Revenue (est.)
Revenue (est.)
£276.9m (FY, 2016)
Revenue (est.)
$817.2m (FY, 2017)
Revenue (est.)
$13.4m (FY, 2017)
Revenue (est.)
$1.1b (FY, 2017)
Revenue (est.)
$8.7b (FY, 2017)
Cost of goods
Cost of goods
£261m (FY, 2016)
Cost of goods
$547.9m (FY, 2017)
Cost of goods
N/A
Cost of goods
$546.3m (FY, 2017)
Cost of goods
$2.5b (FY, 2017)
Gross profit
Gross profit
£16m (FY, 2016)
Gross profit
$269.2m (FY, 2017)
Gross profit
N/A
Gross profit
$510m (FY, 2017)
Gross profit
$6.2b (FY, 2017)
Net income
Net income
£16m (FY, 2016)
Net income
($64.2m) (FY, 2017)
Net income
($127.8m) (FY, 2017)
Net income
($410.5m) (FY, 2017)
Net income
$2.4b (FY, 2017)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 109.5m
Total funding raised
N/A
Total funding raised
$ 63m
Total funding raised
N/A
For sources of this data, please see the company profileDownload Excel

View company profiles

BioScrip
HQ
Denver, US
Employees
2,039

We are a national post-acute solutions provider with over 30 years of experience.

View company
Cytokinetics
HQ
South San Francisco, US
Employees
127

We are focused on discovering and developing muscle activators as drug candidates for debilitating diseases.

View company
Horizon Pharma
HQ
Ballsbridge, IE
Employees
935↓ 9% decrease

Horizon Pharma plc (NASDAQ:HZNP) is a biopharmaceutical company with corporate and EU headquarters in Dublin, Ireland and U.S. headquarters in Lake Forest, IL

View company
Valeant Pharmaceuticals International
HQ
Aliso Viejo, US
Employees
21,500

Valeant Pharmaceuticals International is a multinational specialty pharmaceutical and medical device company.

View company